Structural Formula (Image 01)
Esomeprazole Magnesium
Product Images NDC 50090-4639
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-4639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 Maintenance Of Healing Rates By Month (study 117) (Image 02)
Figure 3 Maintenance Of Healing Rates By Month (study 178) (Image 03)
The image shows the maintenance of healing rates by month in Study 178 with different doses of Esomeprazole Magnesium Delayed-release Capsules and placebo. The percentage of maintenance is shown on the vertical axis and the different doses are shown on the horizontal axis.*
Figure 4 Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)
The text describes a graph titled Figure 4 that shows the percentage of patients who were symptom-free of heartburn by day for a study numbered 225. It shows three bars for Esomeprazole Magnesium Delayed-release Capsules, one with 40mg, one with 20mg and one with a placebo. The x-axis shows the days in the diary, ranging from day 0 to day 28.*
Figure 5 Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)
The figure shows the percentage of patients who were symptom-free of heartburn by day in a particular study labeled 226. There were three treatment groups, namely Esomeprazole Magnesium Delayed-release Capsules 40 mg, Esomeprazole Magnesium Delayed-release Capsules 20 mg, and Placebo. The x-axis represents diary days, while the y-axis represents the percentage of patients symptom-free. The figure shows that both doses of Esomeprazole Magnesium Delayed-release Capsules were effective in treating heartburn, and the percentage of patients symptom-free was higher compared to the placebo group. No additional information is available in the given text.*
Label Image (Lbl500904639)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
